01168nas a2200277   4500000000100000008004100001100001300042700001500055700001300070700001500083700001300098700001400111700001600125700001400141700001400155700001400169700001300183700001600196700001000212700001200222245011200234856007500346300001200421490000700433520045000440       2020                            d1 aRathod S1 aSuneetha S1 aNarang T1 aBhardwaj A1 aGupta SK1 aKamoji SG1 aAshwini P K1 aPradhan S1 aRather SP1 aPatnaik S1 aShanka V1 aJandhyala S1 aRao P1 aDogra S00aManagement of leprosy in the context of COVID‑19 pandemic: Recommendations by SIG leprosy (IADVL academy)  uhttp://www.idoj.in/temp/IndianDermatolOnlineJ113345-2634024_071900.pdf  a345-3480 v113 aRising numbers of COVID‑19 cases in India: The world is facing an unprecedented pandemic of coronavirus (SARS‑CoV‑2)/COVID‑19 with rising numbers being detected in India. The Indian Association of Dermatologists Venereologists and Leprologists (IADVL) Special Interest Group (SIG) on leprosy, with guidance from IADVL academy of Dermatology, has come out with recommendations on the management of leprosy patients in the current context.